Skip to main content
. 2018 Dec 17;220(1):68–72. doi: 10.1093/infdis/jiy663

Table 1.

Participant Demographic Characteristics, by Study Group

HIV Negative, Cognitively Normal (n = 19) HIV Positive, Cognitively Normal (n = 15) HIV Positive, Cognitively Impaired (n = 17) HIV-Negative, Symptomatic Alzheimer Disease (n = 20) P a
Age, y, mean ± SD 61.4 ± 6.1 62.1 ± 7.4 58.5 ± 6.3 73.1 ± 7.2b <.001
Sex .4
 Male 11 (58) 9 (60) 13 (76) 10 (50)
 Female 8 (42) 6 (40) 4 (24) 10 (50)
Education duration, y, mean ± SD 14.1 ± 2.3 13.1 ± 3.0 12.5 ± 2.9 16.9 ± 2.6b .001
CD4+ T-cell count, median (IQR)
 Nadir NA 50 (10–113) 110 (11–454) NA .2
 Recent NA 527 (372–680) 568 (423–866) NA .5
Duration of HIV infection, mo, median (IQR) NA 312 (172–338) 229 (90–273) NA .06
HIV load .7
 Undetectable NA 13 13 NA
 Detectable NA 2 4 NA
Self-reported marijuana use in past 6 mo, participants, % 11 40 35 .13
Self-reported alcohol use in past 6 mo, participants, % 74 53 59 .30
Current smoker, participants, % 16 33 41 .27
Tau PET SUVR, by ROI
 Amygdala 1.0 (0.2) 1.1 (0.3) 1.0 (0.3) 1.6 (0.8)b .04
 Entorhinal 0.9 (0.2) 1.0 (0.2) 1.0 (0.2) 1.4 (0.7)b .017
 Inferior temporal 1.2 (0.1) 1.3 (0.2) 1.2 (0.2) 2.0 (1.0)b .005
 Lateral occipital 1.2 (0.3) 1.4 (0.3) 1.1 (0.2) 1.6 (0.8) .19
 Caudate 1.1 (0.3) 1.1 (0.4) 1.0 (0.4) 1.5 (0.2)b .07
 Putamen 1.4 (0.3) 1.4 (0.3) 1.2 (0.3) 1.7 (0.3) .51
 Frontal 1.0 (0.2) 1.0 (0.2) 1.0 (0.2) 1.3 (0.6)b .05

Data are no. (%) of participants, unless otherwise indicated.

Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range; NA, not applicable; PET, positron emission tomography; ROI, region of interest; SUVR, standardized uptake value ratio.

aBy analysis of variance, the t test, or χ2 analysis.

bSignificantly different from values in the other 3 groups. No other significant group differences were observed.